Aligos Therapeutics Inc
For the period ended Dec 31, 2024. Filed Mar 10, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a)
Documents filed as a part of this Annual Report on Form 10-K:
Financial Statements
The following financial statements are included in Part II, Item 8 of this Annual Report on Form 10-K.
All other schedules have been omitted because they are not required, not applicable, or the required information is otherwise included.
The exhibits listed in the Exhibit Index below are filed or incorporated by reference as part of this Annual Report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.